A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Pathology

• Publication date

  2011-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ajpath.2011.07.006PMID 21854743PMCID PMC3181366
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A(3) adenosine receptor activation during reperfusion reduces infarct size through actions on bone marrow-derived cells.

  2010cited by this paper
• Adenosine receptor A3 is a critical mediator in LPS-induced pulmonary inflammation.

  2010cited by this paper
• The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease.

  2009cited by this paper
• Differential Expression of Adenosine A3 Receptors Controls Adenosine A2A Receptor-Mediated Inhibition of TLR Responses in Microglia

  2009cited by this paper
• The complexity of neurobiological processes in acute ischemic stroke.

  2009cited by this paper
• Post‐ischemic brain damage: pathophysiology and role of inflammatory mediators

  2009cited by this paper
• Activation of the A3 Adenosine Receptor Suppresses Superoxide Production and Chemotaxis of Mouse Bone Marrow Neutrophils

  2008cited by this paper
• Inflammation as therapeutic objective in stroke.

  2008cited by this paper
• Modulation of ischemic brain injury and neuroinflammation by adenosine A2A receptors.

  2008cited by this paper
• Differential neuroprotective effects of a minocycline-based drug cocktail in transient and permanent focal cerebral ischemia.

  2007cited by this paper
• Role of adenosine A3 receptors on CA1 hippocampal neurotransmission during oxygen-glucose deprivation episodes of different duration.

  2007cited by this paper
• Internalization and desensitization of adenosine receptors

  2007cited by this paper
• The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis

  2007cited by this paper
• Cl-IB-MECA [2-Chloro-N6-(3-iodobenzyl)adenosine-5′-N-methylcarboxamide] Reduces Ischemia/Reperfusion Injury in Mice by Activating the A Adenosine Receptor

  2006cited by this paper
• Activation of the Adenosine A3 Receptor in RAW 264.7 Cells Inhibits Lipopolysaccharide-Stimulated Tumor Necrosis Factor-α Release by Reducing Calcium-Dependent Activation of Nuclear Factor-κB and Extracellular Signal-Regulated Kinase 1/2

  2006cited by this paper
• The effect of adenosine receptor agonists on cytokine release by human mononuclear cells depends on the specific Toll-like receptor subtype used for stimulation.

  2006cited by this paper
• Activation of adenosine A3 receptors reduces ischemic brain injury in rodents

  2006cited by this paper
• Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI 3-kinase/Akt and NF-kappaB activation in murine BV2 microglial cells.

  2006cited by this paper
• (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.

  2005cited by this paper
• Accelerated cerebral ischemic injury by activated macrophages/microglia after lipopolysaccharide microinjection into rat corpus callosum

  2005cited by this paper
• Neuropathological endpoints in experimental stroke pharmacotherapy: The importance of both early and late evaluation

  2005cited by this paper
• Intracellular pH-dependent peroxynitrite-evoked synergistic death of glucose-deprived astrocytes.

  2004cited by this paper
• Flavonoids Influence Monocytic GTPase Activity and Are Protective in Experimental Allergic Encephalitis

  2004cited by this paper
• RhoA activation promotes transendothelial migration of monocytes via ROCK

  2004cited by this paper
• Up-Regulation of Cytoskeletal Proteins in Activated Microglia

  2004cited by this paper
• Human cellular inflammation in the pathology of acute cerebral ischaemia

  2003cited by this paper
• Behavioral Characterization of Mice Lacking the A3 Adenosine Receptor: Sensitivity to Hypoxic Neurodegeneration

  2003cited by this paper
• Divergent signals and cytoskeletal assemblies regulate self-organizing polarity in neutrophils.

  2003cited by this paper
• N6-substituted D-4'-thioadenosine-5'-methyluronamides: potent and selective agonists at the human A3 adenosine receptor.

  2003cited by this paper
• The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat.

  2003cited by this paper
• Inhibition of Rho GTPases with Protein Prenyltransferase Inhibitors Prevents Leukocyte Recruitment to the Central Nervous System and Attenuates Clinical Signs of Disease in an Animal Model of Multiple Sclerosis1

  2002cited by this paper
• Right Thing at a Wrong Time?. Adenosine A3 Receptors and Cerebroprotection in Stroke

  2001cited by this paper
• RhoA is required for monocyte tail retraction during transendothelial migration

  2001cited by this paper
• Disruption of the A3 Adenosine Receptor Gene in Mice and Its Effect on Stimulated Inflammatory Cells*

  2000cited by this paper
• Effects of SCH 58261, an Adenosine A2A Receptor Antagonist, on Quinpirole-Induced Turning in 6-Hydroxydopamine-Lesioned Rats: Lack of Tolerance after Chronic Caffeine Intake

  2000cited by this paper
• Cellular signaling in macrophage migration and chemotaxis

  2000cited by this paper
• Pathobiology of ischaemic stroke: an integrated view.

  1999cited by this paper
• Leukocyte polarization in cell migration and immune interactions

  1999cited by this paper
• Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats.

  1999cited by this paper
• An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-gamma production and prevents lethality in endotoxemic mice.

  1998cited by this paper
• Adenosine A3 receptors: novel ligands and paradoxical effects.

  1998cited by this paper
• Suppression of macrophage inflammatory protein (MIP)‐1α production and collagen‐induced arthritis by adenosine receptor agonists

  1998cited by this paper
• Rho GTPases and the actin cytoskeleton.

  1998cited by this paper
• Quantification of infarct size on focal cerebral ischemia model of rats using a simple and economical method.

  1998cited by this paper
• Temporal correlation between adenosine outflow and synaptic potential inhibition in rat hippocampal slices during ischemia-like conditions.

  1998cited by this paper
• Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.

  1998cited by this paper
• Adenosine A3 receptor expression and function in eosinophils.

  1997cited by this paper
• The A3 adenosine receptor mediates cell spreading, reorganization of actin cytoskeleton, and distribution of Bcl-XL: studies in human astroglioma cells.

  1997cited by this paper
• Cloning, characterisation and chromosomal assignment of the human adenosine A3 receptor (ADORA3) gene.

  1997cited by this paper
• Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages.

  1997cited by this paper
• Adenosine A3 receptor agonists inhibit murine macrophage tumor necrosis factor-alpha production in vitro and in vivo.

  1997cited by this paper
• Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model.

  1996cited by this paper
• Short Therapeutic Window for MK-801 in Transient Focal Cerebral Ischemia in Normotensive Rats

  1996cited by this paper
• The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.

  1996cited by this paper
• Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice.

  1996cited by this paper
• Tissue distribution of adenosine receptor mRNAs in the rat

  1996cited by this paper
• Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors.

  1996cited by this paper
• Adenosine A3 receptor stimulation and cerebral ischemia.

  1994cited by this paper
• Glucose metabolism in the infant weighing less than 1100 grams.

  1994cited by this paper
• 2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.

  1994cited by this paper
• MK-801 is neuroprotective but does not improve survival in severe forebrain ischemia.

  1993cited by this paper
• Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages.

  1992cited by this paper
• The dose-response relationship and therapeutic window for dizocilpine (MK-801) in a rat focal ischaemia model.

  1992cited by this paper
• The dose-response relationship and therapeutic window for dizocilpine (MK-801) in a rat focal ischemia model

  1992cited by this paper
• A Semiautomated Method for Measuring Brain Infarct Volume

  1990cited by this paper
• Extracellular Adenosine, Inosine, Hypoxanthine, and Xanthine in Relation to Tissue Nucleotides and Purines in Rat Striatum During Transient Ischemia

  1987cited by this paper
• Dye indicators of membrane potential.

  1979cited by this paper

• Adenosine Receptors in Neuroinflammation and Neurodegeneration

  2025cites this paper
• Structural Simplification from Tricyclic to Bicyclic Scaffolds: A Long-Term Investigation in the Field of Adenosine Receptor Antagonists

  2025cites this paper
• Neuroprotection by Flaxseed Oil in a Model of Hippocampal Injury Induced by Trimethyltin Involves Purinergic System Modulation

  2025cites this paper
• Unlocking the therapeutic capabilities of GPCR in the treatment of ischemic stroke: A translational literature

  2024cites this paper
• Microglia at the blood brain barrier in health and disease

  2024cites this paper
• Adenosine and adenosine receptors in metabolic imbalance-related neurological issues

  2024cites this paper
• Neuroprotective Effects of Pulsed Electromagnetic Fields in Acute Stroke

  2024cites this paper
• Role of Microglia in Stroke.

  2024cites this paper
• Adenosinergic Pathway in Parkinson’s Disease: Recent Advances and Therapeutic Perspective

  2023cites this paper
• The adenosine A2A receptor in the basal ganglia: Expression, heteromerization, functional selectivity and signalling.

  2023cites this paper
• First Potent Macrocyclic A3 Adenosine Receptor Agonists Reveal G-Protein and β-Arrestin2 Signaling Preferences.

  2023cites this paper
• Neuroprotection afforded by targeting G protein-coupled receptors in heteromers and by heteromer-selective drugs

  2023cites this paper
• Abnormal expression of fission and fusion genes and the morphology of mitochondria in eutopic and ectopic endometrium

  2023influential citation
• The role of the ATP-adenosine axis in ischemic stroke

  2023cites this paper
• Gene regulation in activated microglia by adenosine A3 receptor agonists: a transcriptomics study

  2023cites this paper
• A3 adenosine receptor agonist IB-MECA reverses chronic cerebral ischemia-induced inhibitory avoidance memory deficit.

  2022cites this paper
• Species dependence of A3 adenosine receptor pharmacology and function

  2022cites this paper
• Purinergic signaling: a potential therapeutic target for ischemic stroke

  2022cites this paper
• The impact of inosine on hippocampal synaptic transmission and plasticity involves the release of adenosine through equilibrative nucleoside transporters rather than the direct activation of adenosine receptors

  2022cites this paper
• Adenosine A1R/A3R agonist AST-004 reduces brain infarction in mouse and rat models of acute ischemic stroke

  2022cites this paper
• Expression of the Adenosine A2A-A3 Receptor Heteromer in Different Brain Regions and Marked Upregulation in the Microglia of the Transgenic APPSw,Ind Alzheimer’s Disease Model

  2022cites this paper
• Caffeine and Its Neuroprotective Role in Ischemic Events: A Mechanism Dependent on Adenosine Receptors

  2021cites this paper
• Pulsed Electromagnetic Fields: A Novel Attractive Therapeutic Opportunity for Neuroprotection After Acute Cerebral Ischemia.

  2021cites this paper
• Neuroprotective Roles of the Adenosine A3 Receptor Agonist AST-004 in Mouse Model of Traumatic Brain Injury

  2021cites this paper
• G-Protein-Coupled Receptors and Ischemic Stroke: a Focus on Molecular Function and Therapeutic Potential

  2021cites this paper
• LJ529 attenuates mast cell-related inflammation via A3R-PKCε-ALDH2 pathway after subarachnoid hemorrhage in rats.

  2021cites this paper
• Calpain-mediated cleavage of Fbxw7 during excitotoxicity.

  2020cites this paper
• Activation of adenosine A3 receptor reduces early brain injury by alleviating neuroinflammation after subarachnoid hemorrhage in elderly rats

  2020cites this paper
• Adenosine A3 receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury

  2020cites this paper
• Activation of Adenosine A3 Receptor Inhibits Microglia Reactivity Elicited by Elevated Pressure

  2020cites this paper
• Cyclic adenosine monophosphate in acute ischemic stroke: some to update, more to explore.

  2020cites this paper
• Perspective and Potential of A2A and A3 Adenosine Receptors as Therapeutic Targets for the Treatment of Rheumatoid Arthritis.

  2019cites this paper
• Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development

  2019cites this paper
• Current Status in the Design and Development of Agonists and Antagonists of Adenosine A3 Receptor as Potential Therapeutic Agents.

  2019cites this paper
• Role and function of adenosine and its receptors in inflammation, neuroinflammation, IBS, autoimmune inflammatory disorders, rheumatoid arthritis and psoriasis.

  2019cites this paper
• Inflammation in stroke: the role of cholinergic, purinergic and glutamatergic signaling

  2018cites this paper
• Adenosine Receptors and Neuroinflammation

  2018cites this paper
• The Adenosine-Receptor Axis in Chronic Pain

  2018cites this paper
• A3 adenosine receptor agonist attenuates neuropathic pain by suppressing activation of microglia and convergence of nociceptive inputs in the spinal dorsal horn

  2018cites this paper
• Pharmacology of Adenosine Receptors: The State of the Art.

  2018cites this paper
• Adenosine and Oxygen/Glucose Deprivation in the Brain

  2017cites this paper
• A2B adenosine receptors stimulate IL‐6 production in primary murine microglia through p38 MAPK kinase pathway

  2017cites this paper
• N6-Substituted 5'-N-Methylcarbamoyl-4'-selenoadenosines as Potent and Selective A3 Adenosine Receptor Agonists with Unusual Sugar Puckering and Nucleobase Orientation.

  2017cites this paper
• Treadmill exercise promotes neuroprotection against cerebral ischemia–reperfusion injury via downregulation of pro-inflammatory mediators

  2016cites this paper
• Purinergic signalling in brain ischemia.

  2016cites this paper
• How does adenosine control neuronal dysfunction and neurodegeneration?

  2016cites this paper
• South (S)- and North (N)-Methanocarba-7-Deazaadenosine Analogues as Inhibitors of Human Adenosine Kinase.

  2016influential citation
• Treadmill exercise promotes neuroprotection against cerebral ischemia–reperfusion injury via downregulation of pro-inflammatory mediators

  2016cites this paper
• Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity

  2016cites this paper
• Post-ischemic treatment of WIB801C, standardized Cordyceps extract, reduces cerebral ischemic injury via inhibition of inflammatory cell migration.

  2016cites this paper
• Microglia: A Double-Sided Sword in Stroke

  2016cites this paper
• Die autokrine Wachstumsregulation sensorischer Neuronen von Gallus gallus

  2016cites this paper
• Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages – a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape

  2016cites this paper
• Purinergic mechanisms in neuroinflammation: An update from molecules to behavior.

  2016cites this paper
• Treadmill exercise promotes neuroprotection against cerebral ischemia–reperfusion injury via downregulation of pro-inflammatory mediators

  2016cites this paper
• Identification of A3 adenosine receptor agonists as novel non‐narcotic analgesics

  2016cites this paper
• The A3 Adenosine Receptor: History and Perspectives

  2015cites this paper
• Engagement of the GABA to KCC2 Signaling Pathway Contributes to the Analgesic Effects of A3AR Agonists in Neuropathic Pain

  2015cites this paper
• Behavioral / Cognitive Engagement of the GABA to KCC 2 Signaling Pathway Contributes to the Analgesic Effects of A 3 AR Agonists in Neuropathic Pain

  2015cites this paper
• Amelioration of Cerebral Ischemic Injury by a Synthetic Seco-nucleoside LMT497

  2015cites this paper
• The impact of elevated hydrostatic pressure in microglia : chances in the adenosinergic system and inflammatory responses

  2015cites this paper
• Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles.

  2014cites this paper
• Adenosine receptors in cerebral ischemia.

  2014cites this paper
• Purinergic Signaling and Blood Vessels in Health and Disease

  2014cites this paper
• Vascular Inflammation in Ischemic Stroke: Adhesion Receptors Controlling Leukocyte–Endothelial Interactions

  2014cites this paper
• Leukocyte-mediated tissue injury in ischemic stroke.

  2014cites this paper
• The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain

  2014cites this paper
• Gel-based Protease Proteomics for Identifying the Novel Calpain Substrates in Dopaminergic Neuronal Cell*

  2013cites this paper
• Activation of cannabinoid CB2 receptor-mediated AMPK/CREB pathway reduces cerebral ischemic injury.

  2013cites this paper
• GuaLou GuiZhi decoction inhibits LPS-induced microglial cell motility through the MAPK signaling pathway.

  2013cites this paper
• N-Methyl-D-aspartate receptor antagonists memantine and MK-801 attenuate the cerebral infarct accelerated by intracorpus callosum injection of lipopolysaccharides.

  2013cites this paper
• A(1) and A(3) adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes.

  2013cites this paper
• Neurotransmitter signaling in the pathophysiology of microglia

  2013influential citation
• Differential anti-ischemic efficacy and therapeutic time window of trans- and cis-hinokiresinols: stereo-specific antioxidant and anti-inflammatory activities.

  2013cites this paper
• Extracellular nucleotides and adenosine regulate microglial motility and their role in cerebral ischemia

  2013cites this paper
• A2A Adenosine Receptor Signaling in Lymphocytes and the Central Nervous System Regulates Inflammation during Experimental Autoimmune Encephalomyelitis

  2012cites this paper
• Role of TGF-β in Survival of Phagocytizing Microglia: Autocrine Suppression of TNF-α Production and Oxidative Stress

  2012cites this paper
• Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis

  2012cites this paper
• New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors

  2012cites this paper
• This information is current as Encephalomyelitis Experimental Autoimmune System Regulates Inflammation during Lymphocytes and the Central Nervous A 2 A Adenosine Receptor Signaling in

  2012cites this paper
• ADENOSINE BLOOD LEVELS AND COMPLICATIONS OF PREMATURITY IN A SELECTED POPULATION OF VERY LOW BIRTH WEIGHT INFANTS

  year unknowncites this paper